HBsAg subtypes among HBsAg carriers in Okinawa, Japan. Evidence of an important relationship in seroconversion from HBeAg to anti-HBe. 1994

A Noguchi, and J Hayashi, and K Nakashima, and M Hirata, and H Ikematsu, and S Kashiwagi
Department of General Medicine, Kyushu University Hospital, Japan.

In Okinawa, Japan 1261 hepatitis B surface antigen (HBsAg) carriers were investigated for clinical differences among HBsAg subtypes. Among the 854 for whom they could be determined, subtype adw was found in 604 (70.7%), adr in 232 (27.2%) and others in 18 (2.1%). The overall prevalence of hepatitis B e antigen (HBeAg) was significantly lower in subtype adw (11.9%) than in adr (17.7%) (P < 0.01). The mean age of HBeAg-positive carriers was significantly lower in adw (20.4 years) than in adr (26.9 years) (P < 0.05). Seroconversion from HBeAg to antibody to HBeAg (anti-HBe) occurred in 43 carriers. The seroconversion rate was higher in adw (43.1%) than in adr (29.3%) and the seroconversion age was younger in adw (22.7 years) than in adr (27.9 years). These results suggest that carriers with subtype adw tend to seroconvert from HBeAg to anti-HBe at a higher rate and a younger age than do those with adr. HBsAg subtypes may be closely associated with the HBeAg/anti-HBe status.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti

Related Publications

A Noguchi, and J Hayashi, and K Nakashima, and M Hirata, and H Ikematsu, and S Kashiwagi
January 1979, Vox sanguinis,
A Noguchi, and J Hayashi, and K Nakashima, and M Hirata, and H Ikematsu, and S Kashiwagi
November 1985, Gematologiia i transfuziologiia,
A Noguchi, and J Hayashi, and K Nakashima, and M Hirata, and H Ikematsu, and S Kashiwagi
January 1986, Microbiology and immunology,
A Noguchi, and J Hayashi, and K Nakashima, and M Hirata, and H Ikematsu, and S Kashiwagi
July 1991, The American journal of gastroenterology,
A Noguchi, and J Hayashi, and K Nakashima, and M Hirata, and H Ikematsu, and S Kashiwagi
June 1978, Zeitschrift fur Immunitatsforschung. Immunobiology,
A Noguchi, and J Hayashi, and K Nakashima, and M Hirata, and H Ikematsu, and S Kashiwagi
October 1979, Zeitschrift fur Gastroenterologie,
A Noguchi, and J Hayashi, and K Nakashima, and M Hirata, and H Ikematsu, and S Kashiwagi
January 1989, Japanese journal of medicine,
A Noguchi, and J Hayashi, and K Nakashima, and M Hirata, and H Ikematsu, and S Kashiwagi
November 1981, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
A Noguchi, and J Hayashi, and K Nakashima, and M Hirata, and H Ikematsu, and S Kashiwagi
January 1980, Journal of medical virology,
A Noguchi, and J Hayashi, and K Nakashima, and M Hirata, and H Ikematsu, and S Kashiwagi
August 2008, Bangladesh Medical Research Council bulletin,
Copied contents to your clipboard!